Clinical Trials in Dothan, Alabama

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

NCT ID: NCT06052059

This clinical trial is studying a new medication called tulisokibart (MK-7240) to see if it is effective and safe for people with moderately to severely active ulcerative colitis, a condition that ...

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

NCT ID: NCT06430801

This clinical trial is studying a new medication called tulisokibart, which is being tested for its effectiveness and safety in treating people with moderate to severe Crohn's disease. Crohn's dise...

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

NCT ID: NCT06548542

This clinical trial is exploring new targeted therapies to treat adults with moderate to severe Crohn's Disease, a long-lasting condition that causes inflammation in the digestive tract and can lea...

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

NCT ID: NCT07037459

This clinical trial is studying a medicine called maridebart cafraglutide to see if it can help people who have heart failure with either preserved or mildly reduced heart function, and who are als...

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

NCT ID: NCT04987229

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

NCT ID: NCT05303064

This clinical trial is studying how a new treatment, OLZ/SAM, affects weight gain in young people with schizophrenia or bipolar I disorder compared to a standard medication called olanzapine. The r...

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NCT ID: NCT06215716

This clinical trial is studying a medication called efruxifermin (EFX) to see if it can help people with non-cirrhotic Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steato...

Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome

NCT ID: NCT06315751

This clinical trial is studying a new medication called gemlapodect (NOE-105) to see how well it works and how safe it is for reducing tics in adults and adolescents with Tourette Syndrome (TS). Th...

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

NCT ID: NCT05769153

This clinical trial is investigating a new treatment called AR-14034 for patients with neovascular age-related macular degeneration (nAMD), a condition that can lead to vision loss. The main goal o...

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NCT ID: NCT06528314

This clinical trial is studying a new medication called efruxifermin (EFX) for people with compensated cirrhosis caused by nonalcoholic steatohepatitis (NASH) or metabolic dysfunction-associated st...

A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

NCT ID: NCT06589986

This clinical trial is studying a new medication called RO7790121 to see how well it works and how safe it is for people with moderately to severely active ulcerative colitis (UC), which is a condi...

Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

NCT ID: NCT07082816

This clinical trial is testing a new eye drop called Reformulated PG324 to see if it can safely and effectively lower eye pressure in people who have open-angle glaucoma or ocular hypertension. The...

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

NCT ID: NCT05563220

This clinical trial is studying a new medication called elacestrant, which is being tested in combination with other treatments for patients with advanced or metastatic breast cancer that is positi...

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

NCT ID: NCT06095128

This clinical trial is studying the combined effect of two medications, vedolizumab and tofacitinib, in adults with moderate to severe ulcerative colitis (UC). The goal is to see how well this comb...

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

NCT ID: NCT06868264

The C-BEYOND clinical trial is studying two different treatment options for adults with chronic Hepatitis C virus (HCV) infection: BEM/RZR and SOF/VEL. The main goal is to find out which treatment ...

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

NCT ID: NCT03891446

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

NCT ID: NCT06292013

The ACCLAIM-Lp(a) trial is studying a new treatment called lepodisiran to see if it can help reduce the risk of serious heart problems in adults who have high levels of a substance called lipoprote...

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT ID: NCT06937086

This clinical trial is investigating whether a combination of two medications, mirikizumab and tirzepatide, can help adults with ulcerative colitis (UC) and obesity or overweight to reduce their UC...

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

NCT ID: NCT06937099

This clinical trial is investigating the effectiveness and safety of a treatment combining two medications, mirikizumab and tirzepatide, for adults who have Crohn's disease that is moderately to se...

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

NCT ID: NCT05966493

This clinical trial is looking at a new treatment called NEXAGON® (lufepirsen ophthalmic gel) for people with Persistent Corneal Epithelial Defect (PCED). PCED is a condition where the surface of t...